Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 3/20 | 0.54 |
| ▸ | RAB9A | P51151 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.54 |
| ▸ | VCP | P55072 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | GABRP | O00591 | 1/20 | 0.47 |
| ▸ | GABRD | O14764 | 1/20 | 0.47 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.47 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.47 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.47 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.47 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.47 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28910080 | 0.86 | NPC1 (0.46) | NPSR1NPC1RAB9AMEN1POLB | |
| SCHEMBL1686093 | 0.84 | NPSR1 (0.52) | NPSR1NPC1RAB9AMEN1POLB | |
| SCHEMBL777600 | 0.83 | NPSR1 (0.53) | NPSR1NPC1RAB9AMEN1POLB | |
| SCHEMBL18485604 | 0.82 | NPSR1 (0.57) | NPSR1NPC1RAB9AMEN1POLB | |
| SCHEMBL6834747 | 0.82 | APP (0.52) | NPC1RAB9AMEN1POLBKMT2A | |
| SCHEMBL11902648 | 0.82 | GABRP (0.49) | NPC1RAB9AMEN1POLBKMT2A | |
| SCHEMBL5947105 | 0.81 | FFAR1 (0.66) | NPC1RAB9AMEN1KMT2AALDH1A1 | |
| SCHEMBL9202331 | 0.81 | FFAR1 (0.62) | NPC1RAB9AALDH1A1LMNAL3MBTL1 | |
| SCHEMBL10753043 | 0.80 | APP (0.50) | NPC1RAB9AMEN1POLBKMT2A | |
| SCHEMBL9432042 | 0.80 | GABRP (0.48) | RAB9AMEN1POLBKMT2ANLRP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 276 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028554-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING AROMATIC DERIVATIVES | OSMO LABS PBC (US) | 2026-01-29 | — | — | US | claimed |
| CN-116903866-A | Polyvinyl alcohol modified multifunctional powder slump retaining agent and preparation method thereof | 江苏奥莱特新材料股份有限公司 | 2023-10-20 | — | — | CN | claimed |
| WO-2018167801-A1 | NOVEL TRICYCLIC COMPOUNDS, PROCESS FOR PREPARATION AND USE THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2018-09-20 | — | — | WO | claimed |
| CN-106496087-B | A kind of method by the decarboxylation coupling reaction one pot process compound of class containing selenium | 广西师范大学 | 2018-01-23 | — | — | CN | claimed |
| EP-3051946-B1 | USE OF SUBSTITUTED DIHYDROOXINDOLYLSULFONAMIDES OR THEIR SALTS FOR INCREASING STRESS TOLERANCE IN PLANTS | BAYER CROPSCIENCE AG (DE) | 2017-11-29 | — | — | EP | claimed |
| CN-106496087-A | A kind of method by the decarboxylation coupling reaction one pot process compound of class containing selenium | 广西师范大学 | 2017-03-15 | — | — | CN | claimed |
| CN-106380446-A | Synthesis method of quinoline-2-formic acid ester derivatives | 南阳师范学院 | 2017-02-08 | — | — | CN | claimed |
| CN-106380463-A | Method for synthesis of quinoline derivatives | 南阳师范学院 | 2017-02-08 | — | — | CN | claimed |
| CN-106366035-A | Method for synthesizing quinoline derivative | 南阳师范学院 | 2017-02-01 | — | — | CN | claimed |
| CN-106349147-A | Synthetic method of pyrrole derivatives | 南阳师范学院 | 2017-01-25 | — | — | CN | claimed |
| US-8822628-B2 | Crosslinkable liquid crystalline polymer | TICONA LLC (US) | 2014-09-02 | — | — | US | claimed |
| CN-104003995-A | Pyrone-[3, 4-b] indole derivative and synthetic method thereof | UNIV SHANGHAI JIAOTONG | 2014-08-27 | — | — | CN | claimed |
| US-20140088285-A1 | Crosslinkable Liquid Crystalline Polymer | TICONA LLC (US) | 2014-03-27 | — | — | US | claimed |
| EP-1618088-A1 | STABILIZED ORGANIC PEROXIDE COMPOSITION AND PROCESS FOR MAKING THE SAME | CHEMTURA CORPORATION (US) | 2006-01-25 | — | — | EP | claimed |
| US-6893584-B2 | Stabilized organic peroxide composition and process for making the same | CROMPTON CORPORATION (US) | 2005-05-17 | — | — | US | claimed |
| WO-2004096762-A1 | STABILIZED ORGANIC PEROXIDE COMPOSITION AND PROCESS FOR MAKING THE SAME | CHEMTURA CORPORATION (US) | 2004-11-11 | — | — | WO | claimed |
| US-20040211938-A1 | Stabilized organic peroxide composition and process for making the same | CROMPTON CORPORATION | 2004-10-28 | — | — | US | claimed |
| EP-1053224-B1 | BIPHENYLSULFONYL CYANAMIDES, METHOD FOR THE PRODUCTION THEREOF AND THEIR UTILIZATION AS A MEDICAMENT | AVENTIS PHARMA GMBH (DE) | 2002-08-21 | — | — | EP | claimed |
| EP-0099329-A1 | Dithio compounds, pharmaceutical preparations containing them and their use | Zyma SA (CH) | 1984-01-25 | — | — | EP | claimed |
| JP-56097250-A | — | — | None | — | — | JP | disclosed |
| CN-116903866-B | Polyvinyl alcohol modified multifunctional powder slump retaining agent and preparation method thereof | JIANGSU ARIT NEW MATERIALS CO.,LTD. (CN) | 2026-05-26 | — | — | CN | disclosed |
| US-20260078120-A1 | SUBSTITUTED PYRIDOPYRIMIDINONES | Mirati Therapeutics, Inc. (US) | 2026-03-19 | — | — | US | disclosed |
| EP-4121421-B1 | BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS | NOVARTIS AG (CH) | 2026-03-11 | — | — | EP | disclosed |
| US-20260028554-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING AROMATIC DERIVATIVES | OSMO LABS PBC (US) | 2026-01-29 | — | — | US | disclosed |
| EP-3745105-B1 | TEMPERATURE DETECTION LABEL AND ARTICLE MANAGEMENT DEVICE USING SAME | HITACHI LTD (JP) | 2025-08-27 | — | — | EP | disclosed |
| EP-4577544-A1 | SUBSTITUTED PYRIDOPYRIMIDINONES | Mirati Therapeutics, Inc. (US) | 2025-07-02 | — | — | EP | disclosed |
| US-12263159-B2 | Fused ring compound having urea structure | Sanford Burnham Prebys Medical Discovery Institute (US) | 2025-04-01 | — | — | US | disclosed |
| EP-4516822-A1 | PRODUCTION METHOD FOR PRODUCING REACTIVE SILICON GROUP-CONTAINING ORGANIC POLYMER | AGC Inc. (JP) | 2025-03-05 | — | — | EP | disclosed |
| US-20250051493-A1 | PRODUCTION METHOD FOR PRODUCING REACTIVE SILICON GROUP-CONTAINING ORGANIC POLYMER | AGC Inc. (JP) | 2025-02-13 | — | — | US | disclosed |
| US-20240400247-A1 | TEMPERATURE INDICATOR MANUFACTURING SYSTEM AND TEMPERATURE INDICATOR MANUFACTURING METHOD | HITACHI INDUSTRIAL EQUIPMENT SYSTEMS CO., LTD. (JP) | 2024-12-05 | — | — | US | disclosed |
| US-20240397811-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-11-28 | — | — | US | disclosed |
| US-20240382457-A1 | BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS | NOVARTIS PHARMA AG (CH) | 2024-11-21 | — | — | US | disclosed |
| EP-4431889-A1 | TEMPERATURE INDICATOR MANUFACTURING SYSTEM AND TEMPERATURE INDICATOR MANUFACTURING METHOD | Hitachi Industrial Equipment Systems Co., Ltd. (JP) | 2024-09-18 | — | — | EP | disclosed |
| US-12083101-B2 | Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors | NOVARTIS AG (CH) | 2024-09-10 | — | — | US | disclosed |
| US-12085452-B2 | Temperature detection ink, temperature detection ink initialization method, temperature indicator, and article management system | HITACHI INDUSTRIAL EQUIPMENT SYSTEMS CO., LTD. (JP) | 2024-09-10 | — | — | US | disclosed |
| US-20240285597-A1 | FUSED RING COMPOUND HAVING UREA STRUCTURE | DAIICHI SANKYO COMPANY LIMITED (JP) | 2024-08-29 | — | — | US | disclosed |
| US-12075691-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2024-08-27 | — | — | US | disclosed |
| EP-3614113-B1 | TEMPERATURE DETECTING MATERIAL AND PRODUCT CONTROL METHOD | HITACHI INDUSTRY EQUIPMENT SYSTEMS CO LTD (JP) | 2024-07-17 | — | — | EP | disclosed |
| WO-2024142146-A1 | TEMPERATURE INDICATOR AND METHOD FOR PRODUCING TEMPERATURE INDICATOR | 株式会社日立産機システム | 2024-07-04 | — | — | WO | disclosed |
| EP-3730911-B1 | TEMPERATURE SENSING MATERIAL, AND TEMPERATURE DEVIATION TIME ESTIMATING SYSTEM EMPLOYING SAME | HITACHI INDUSTRY EQUIPMENT SYSTEMS CO LTD (JP) | 2024-05-01 | — | — | EP | disclosed |
| US-11933677-B2 | Temperature detecting material, temperature detecting ink using same, temperature indicator, and product control system | HITACHI INDUSTRIAL EQUIPMENT SYSTEMS CO., LTD. (JP) | 2024-03-19 | — | — | US | disclosed |
| US-11918568-B2 | Fused ring compound having urea structure | Sanford Burnham Prebys Medical Discovery Institute (US) | 2024-03-05 | — | — | US | disclosed |
| WO-2024044769-A1 | SUBSTITUTED PYRIDOPYRIMIDINONES | Mirati Therapeutics, Inc. (US) | 2024-02-29 | — | — | WO | disclosed |
| US-20240034723-A1 | PIPERIDINYL SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2024-02-01 | — | — | US | disclosed |
| EP-3557208-B1 | TEMPERATURE DETECTION MATERIAL AND METHODS FOR MANUFACTURING A TEMPERATURE DETECTION MATERIAL | HITACHI INDUSTRY EQUIPMENT SYSTEMS CO LTD (JP) | 2024-01-10 | — | — | EP | disclosed |
| CN-115197108-B | Preparation method of gamma-ketosulfone compound | 南华大学 | 2023-11-28 | — | — | CN | disclosed |
| WO-2023210586-A1 | PRODUCTION METHOD FOR PRODUCING REACTIVE SILICON GROUP-CONTAINING ORGANIC POLYMER | ＡＧＣ株式会社 | 2023-11-02 | — | — | WO | disclosed |
| EP-3745106-B1 | TEMPERATURE DETECTION INK, TEMPERATURE DETECTION INK INITIALIZATION METHOD, TEMPERATURE INDICATOR, AND ARTICLE MANAGEMENT SYSTEM | HITACHI INDUSTRY EQUIPMENT SYSTEMS CO LTD (JP) | 2023-10-25 | — | — | EP | disclosed |
| CN-116903866-A | Polyvinyl alcohol modified multifunctional powder slump retaining agent and preparation method thereof | 江苏奥莱特新材料股份有限公司 | 2023-10-20 | — | — | CN | disclosed |
| EP-4228651-A1 | PIPERIDINYL SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE | Dana-Farber Cancer Institute, Inc. (US) | 2023-08-23 | — | — | EP | disclosed |
| WO-2023079780-A1 | TEMPERATURE INDICATOR MANUFACTURING SYSTEM AND TEMPERATURE INDICATOR MANUFACTURING METHOD | 株式会社日立産機システム | 2023-05-11 | — | — | WO | disclosed |
| US-11635335-B2 | Temperature sensing material, and temperature deviation time estimating system employing same | HITACHI INDUSTRIAL EQUIPMENT SYSTEMS CO., LTD. (JP) | 2023-04-25 | — | — | US | disclosed |
| EP-3818053-B1 | FUSED RING COMPOUND HAVING UREA STRUCTURE | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST (US) | 2023-03-29 | — | — | EP | disclosed |
| US-11572486-B2 | Temperature detection material, temperature detection ink using same, temperature indicator, method for manufacturing temperature detection material, and product management system | HITACHI INDUSTRIAL EQUIPMENT SYSTEMS CO., LTD. (JP) | 2023-02-07 | — | — | US | disclosed |
| EP-4121421-A1 | BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS | Novartis AG (CH) | 2023-01-25 | — | — | EP | disclosed |
| CN-115477606-A | Method for quickly converting ester into alkyne | 中国科学院兰州化学物理研究所 | 2022-12-16 | — | — | CN | disclosed |
| CN-115197108-A | Preparation method of gamma-ketosulfone compound | 南华大学 | 2022-10-18 | — | — | CN | disclosed |
| US-11397115-B2 | Temperature detection label and article management device using same | HITACHI, LTD. (JP) | 2022-07-26 | — | — | US | disclosed |
| EP-3268375-B1 | PHOTOCHROMIC THIENOCHROMENE COMPOUNDS | TRANSITIONS OPTICAL INC (US) | 2022-06-15 | — | — | EP | disclosed |
| WO-2022081976-A1 | PIPERIDINYL SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2022-04-21 | — | — | WO | disclosed |
| WO-2022032144-A1 | SUBSTRATE ADAPTOR INHIBITORS OF PRMT5 AND USES THEREOF | THE BROAD INSTITUTE, INC. (US) | 2022-02-10 | — | — | WO | disclosed |
| EP-3071576-B9 | PHOTOCHROMIC INDENO-FUSED RING PYRAN COMPOUNDS | TRANSITIONS OPTICAL INC (US) | 2021-12-22 | — | — | EP | disclosed |
| US-20210361636-A1 | FUSED RING COMPOUND HAVING UREA STRUCTURE | DAIICHI SANKYO COMPANY LIMITED (JP) | 2021-11-25 | — | — | US | disclosed |
| US-20210299100-A1 | BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS | NOVARTIS PHARMA AG (CH) | 2021-09-30 | — | — | US | disclosed |
| WO-2021186324-A1 | BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS | NOVARTIS AG (CH) | 2021-09-23 | — | — | WO | disclosed |
| EP-3071576-B1 | PHOTOCHROMIC INDENO-FUSED RING PYRAN COMPOUNDS | TRANSITIONS OPTICAL INC (US) | 2021-08-18 | — | — | EP | disclosed |
| EP-3818053-A1 | FUSED RING COMPOUND HAVING UREA STRUCTURE | Sanford Burnham Prebys Medical Discovery Institute (US) | 2021-05-12 | — | — | EP | disclosed |
| WO-2021059568-A1 | INK, METHOD FOR PRODUCING SAID INK, AND TEMPERATURE INDICATOR USING SAID INK | 株式会社日立産機システム | 2021-04-01 | — | — | WO | disclosed |
| US-20210063252-A1 | Temperature Detection Ink, Temperature Detection Ink Initialization Method, Temperature Indicator, and Article Management System | HITACHI INDUSTRIAL EQUIPMENT SYSTEMS CO., LTD. (JP) | 2021-03-04 | — | — | US | disclosed |
| CN-112390830-A | Iridium catalyst for catalyzing rearrangement of propargyl ester to prepare substituted ketone compound | 江南大学 | 2021-02-23 | — | — | CN | disclosed |
| US-20210010873-A1 | Temperature Sensing Material, and Temperature Deviation Time Estimating System Employing Same | HITACHI INDUSTRIAL EQUIPMENT SYSTEMS CO., LTD. (JP) | 2021-01-14 | — | — | US | disclosed |
| EP-3745105-A1 | TEMPERATURE DETECTION LABEL AND ARTICLE MANAGEMENT DEVICE USING SAME | Hitachi, Ltd. (JP) | 2020-12-02 | — | — | EP | disclosed |
| EP-3745106-A1 | TEMPERATURE DETECTION INK, TEMPERATURE DETECTION INK INITIALIZATION METHOD, TEMPERATURE INDICATOR, AND ARTICLE MANAGEMENT SYSTEM | HITACHI INDUSTRIAL EQUIPMENT SYSTEMS CO., LTD. (JP) | 2020-12-02 | — | — | EP | disclosed |
| US-20200350502-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-11-05 | — | — | US | disclosed |
| EP-3730911-A1 | TEMPERATURE SENSING MATERIAL, AND TEMPERATURE DEVIATION TIME ESTIMATING SYSTEM EMPLOYING SAME | HITACHI INDUSTRIAL EQUIPMENT SYSTEMS CO., LTD. (JP) | 2020-10-28 | — | — | EP | disclosed |
| US-20200278263-A1 | Temperature Detection Label and Article Management Device Using Same | HITACHI, LTD. (JP) | 2020-09-03 | — | — | US | disclosed |
| US-20200158579-A1 | TEMPERATURE EVALUATION SYSTEM, AND ARTICLE MANAGEMENT SYSTEM IN WHICH SAME IS USED | HITACHI, LTD. (JP) | 2020-05-21 | — | — | US | disclosed |
| EP-3614112-A1 | TEMPERATURE EVALUATION SYSTEM, AND ARTICLE MANAGEMENT SYSTEM IN WHICH SAME IS USED | Hitachi, Ltd. (JP) | 2020-02-26 | — | — | EP | disclosed |
| EP-3614113-A1 | TEMPERATURE DETECTION MATERIAL, TEMPERATURE DETECTION INK USING SAME, TEMPERATURE INDICATOR, AND ARTICLE MANAGEMENT SYSTEM | HITACHI INDUSTRIAL EQUIPMENT SYSTEMS CO., LTD. (JP) | 2020-02-26 | — | — | EP | disclosed |
| US-20200041359-A1 | Temperature Detecting Material, Temperature Detecting Ink Using Same, Temperature Indicator, and Product Control System | HITACHI INDUSTRIAL EQUIPMENT SYSTEMS CO., LTD. (JP) | 2020-02-06 | — | — | US | disclosed |
| EP-3557208-A1 | TEMPERATURE DETECTION MATERIAL, TEMPERATURE DETECTION INK USING SAME, TEMPERATURE INDICATOR, METHOD FOR MANUFACTURING TEMPERATURE DETECTION MATERIAL, AND PRODUCT MANAGEMENT SYSTEM | HITACHI INDUSTRIAL EQUIPMENT SYSTEMS CO., LTD. (JP) | 2019-10-23 | — | — | EP | disclosed |
| US-20190300740-A1 | Temperature Detection Material, Temperature Detection Ink Using Same, Temperature Indicator, Method for Manufacturing Temperature Detection Material, and Product Management System | HITACHI INDUSTRIAL EQUIPMENT SYSTEMS CO., LTD. (JP) | 2019-10-03 | — | — | US | disclosed |
| CN-109776253-A | Alcohol hydrogen supply palladium chtalyst alkynes semi-reduction selectivity synthesis is suitable, trans olefins methods | 南通大学 | 2019-05-21 | — | — | CN | disclosed |
| EP-2935292-B1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2019-04-10 | — | — | EP | disclosed |
| CN-109485814-A | A kind of method that alkynes, amine and aldehyde multicomponent polymerization prepare carbene propyl amine | 华南理工大学 | 2019-03-19 | — | — | CN | disclosed |
| EP-3071550-B1 | METHOD OF PREPARING FUSED RING INDENO COMPOUNDS | TRANSITIONS OPTICAL INC (US) | 2019-03-13 | — | — | EP | disclosed |
| CN-106543232-B | Metal bridge location fused ring compound and its preparation method and application | 厦门大学 | 2019-01-11 | — | — | CN | disclosed |
| EP-2684881-B1 | FLUORESCENCE COMPOUND, ION CONCENTRATION SENSOR INCLUDING THE COMPOUND, REAGENT INCLUDING COMPOUND, REAGENT KIT PROVIDED WITH REAGENT, AND METHOD FOR SYNTHESIZING COMPOUND | UNIV HOKKAIDO NAT UNIV CORP (JP) | 2018-11-28 | — | — | EP | disclosed |
| WO-2018167801-A1 | NOVEL TRICYCLIC COMPOUNDS, PROCESS FOR PREPARATION AND USE THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2018-09-20 | — | — | WO | disclosed |
| CN-108404983-A | A kind of preparation and its application of ordered mesoporous phenolic resin Polymer-supported silver catalyst | 华东师范大学 | 2018-08-17 | — | — | CN | disclosed |
| EP-1904069-B1 | ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN | ALBANY MOLECULAR RES INC (US) | 2018-06-13 | — | — | EP | disclosed |
| US-20180051037-A1 | Photochromic Thienochromene Compounds | TRANSITIONS OPTICAL, INC. | 2018-02-22 | — | — | US | disclosed |
| US-20180051037-A1 | Photochromic Thienochromene Compounds | TRANSITIONS OPTICAL, INC. | 2018-02-22 | — | — | US | disclosed |
| CN-106496087-B | A kind of method by the decarboxylation coupling reaction one pot process compound of class containing selenium | 广西师范大学 | 2018-01-23 | — | — | CN | disclosed |
| CN-107556269-A | The synthetic method of α alkynyl substituted ether compounds | 南京理工大学 | 2018-01-09 | — | — | CN | disclosed |
| US-20170267824-A1 | PREPREG COMPOSITE CONTAINING A CROSSLINKED AROMATIC POLYESTER | TICONA LLC | 2017-09-21 | — | — | US | disclosed |
| US-9686990-B2 | Spiroindolinepiperidine derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2017-06-27 | — | — | US | disclosed |
| US-9686990-B2 | Spiroindolinepiperidine derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2017-06-27 | — | — | US | disclosed |
| CN-106883189-A | The method for synthesizing the triazole compound containing selenium with diselenide, acetylenic acid and nitrine | 广西师范大学 | 2017-06-23 | — | — | CN | disclosed |
| US-9630902-B2 | Method of preparing fused ring indeno compounds | TRANSITIONS OPTICAL, INC. (US) | 2017-04-25 | — | — | US | disclosed |
| US-9630902-B2 | Method of preparing fused ring indeno compounds | TRANSITIONS OPTICAL, INC. (US) | 2017-04-25 | — | — | US | disclosed |
| EP-2513029-B1 | CARBOXYLATION OF TERMINAL ALKYNES | AGENCY SCIENCE TECH & RES (SG) | 2017-04-05 | — | — | EP | disclosed |
| CN-106543232-A | Metal bridge location fused ring compound and its production and use | 厦门大学 | 2017-03-29 | — | — | CN | disclosed |
| CN-106496087-A | A kind of method by the decarboxylation coupling reaction one pot process compound of class containing selenium | 广西师范大学 | 2017-03-15 | — | — | CN | disclosed |
| CN-106380446-A | Synthesis method of quinoline-2-formic acid ester derivatives | 南阳师范学院 | 2017-02-08 | — | — | CN | disclosed |
| CN-106380463-A | Method for synthesis of quinoline derivatives | 南阳师范学院 | 2017-02-08 | — | — | CN | disclosed |
| CN-106366035-A | Method for synthesizing quinoline derivative | 南阳师范学院 | 2017-02-01 | — | — | CN | disclosed |
| CN-106349147-A | Synthetic method of pyrrole derivatives | 南阳师范学院 | 2017-01-25 | — | — | CN | disclosed |
| CN-104003995-B | Pyranone also [3,4-b] indole derivatives and synthetic method thereof | 上海交通大学 | 2016-10-26 | — | — | CN | disclosed |
| US-9403776-B2 | Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin | ALBANY MOLECULAR RESEARCH, INC. (US) | 2016-08-02 | — | — | US | disclosed |
| US-20160209561-A1 | Photochromic Articles That Include Photochromic-Dichroic Materials | TRANSITIONS OPTICAL, INC. | 2016-07-21 | — | — | US | disclosed |
| US-20160209561-A1 | Photochromic Articles That Include Photochromic-Dichroic Materials | TRANSITIONS OPTICAL, INC. | 2016-07-21 | — | — | US | disclosed |
| EP-3045971-A1 | PHOTOCHROMIC COMPOUNDS AND COMPOSITIONS | Transitions Optical, Inc. (US) | 2016-07-20 | — | — | EP | disclosed |
| US-9334439-B2 | Photochromic articles that include photochromic-dichroic materials | TRANSITIONS OPTICAL, INC. (US) | 2016-05-10 | — | — | US | disclosed |
| US-9334439-B2 | Photochromic articles that include photochromic-dichroic materials | TRANSITIONS OPTICAL, INC. (US) | 2016-05-10 | — | — | US | disclosed |
| EP-2652553-B1 | PHOTOCHROMIC COMPOUNDS AND COMPOSITIONS | TRANSITIONS OPTICAL INC (US) | 2016-04-06 | — | — | EP | disclosed |
| US-20160060205-A1 | Method Of Preparing Fused Ring Indeno Compounds | TRANSITIONS OPTICAL, INC. | 2016-03-03 | — | — | US | disclosed |
| US-20160060205-A1 | Method Of Preparing Fused Ring Indeno Compounds | TRANSITIONS OPTICAL, INC. | 2016-03-03 | — | — | US | disclosed |
| EP-2331502-B1 | COMPOUNDS FOR THE TREATMENT OF HEPATITIS C | BRISTOL MYERS SQUIBB CO (US) | 2016-03-02 | — | — | EP | disclosed |
| US-20160007608-A1 | SPIROINDOLINEPIPERIDINE DERIVATIVES | SYNGENTA LIMITED (GB) | 2016-01-14 | — | — | US | disclosed |
| US-9222016-B2 | Compound having fluorescent chromophore, ion concentration sensor including compound, reagent including compound, reagent kit provided with reagent, precursor of compound, and method for synthesizing compound | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2015-12-29 | — | — | US | disclosed |
| US-9206151-B2 | Method of preparing fused ring indeno compounds | TRANSITIONS OPTICAL, INC. (US) | 2015-12-08 | — | — | US | disclosed |
| US-9206151-B2 | Method of preparing fused ring indeno compounds | TRANSITIONS OPTICAL, INC. (US) | 2015-12-08 | — | — | US | disclosed |
| CN-102958888-B | End alkynes carboxylated | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-11-25 | — | — | CN | disclosed |
| US-20150333280-A1 | Metal Complexes | MERCK PATENT GMBH (DE) | 2015-11-19 | — | — | US | disclosed |
| US-20150333280-A1 | Metal Complexes | MERCK PATENT GMBH (DE) | 2015-11-19 | — | — | US | disclosed |
| US-20150333280-A1 | Metal Complexes | MERCK PATENT GMBH (DE) | 2015-11-19 | — | — | US | disclosed |
| US-9174987-B2 | Spiroindolinepiperidine derivatives | SYNGENTA LIMITED (DE) | 2015-11-03 | — | — | US | disclosed |
| US-20150274886-A1 | Crosslinkable Soluble Aromatic Polyester | TICONA LLC | 2015-10-01 | — | — | US | disclosed |
| US-9145519-B2 | Crosslinkable aromatic polyester | TICONA LLC (US) | 2015-09-29 | — | — | US | disclosed |
| CN-103159761-B | Simple preparation method of 3-aryl indolizine derivative | HUAIYIN TEACHER COLLEGE | 2015-06-10 | — | — | CN | disclosed |
| US-9051332-B1 | Photochromic indeno-fused ring pyran compounds | TRANSITIONS OPTICAL, INC. (US) | 2015-06-09 | — | — | US | disclosed |
| US-9051332-B1 | Photochromic indeno-fused ring pyran compounds | TRANSITIONS OPTICAL, INC. (US) | 2015-06-09 | — | — | US | disclosed |
| WO-2015077147-A1 | METHOD OF PREPARING FUSED RING INDENO COMPOUNDS | TRANSITIONS OPTICAL, INC. (US) | 2015-05-28 | — | — | WO | disclosed |
| WO-2015077141-A1 | FUSED RING INDENO COMPOUNDS FOR PREPARATION OF PHOTOCHROMIC COMPOUNDS | TRANSITIONS OPTICAL, INC. (US) | 2015-05-28 | — | — | WO | disclosed |
| WO-2015077264-A1 | PHOTOCHROMIC INDENO-FUSED RING PYRAN COMPOUNDS | TRANSITIONS OPTICAL, INC. (US) | 2015-05-28 | — | — | WO | disclosed |
| US-20150141661-A1 | Photochromic Indeno-Fused Ring Pyran Compounds | TRANSITIONS OPTICAL, INC. (US) | 2015-05-21 | — | — | US | disclosed |
| US-20150141661-A1 | Photochromic Indeno-Fused Ring Pyran Compounds | TRANSITIONS OPTICAL, INC. (US) | 2015-05-21 | — | — | US | disclosed |
| US-20150141663-A1 | Fused Ring Indeno Compounds For Preparation Of Photochromic Compounds | TRANSITIONS OPTICAL, INC. (US) | 2015-05-21 | — | — | US | disclosed |
| US-20150141662-A1 | Method Of Preparing Fused Ring Indeno Compounds | TRANSITIONS OPTICAL, INC. (US) | 2015-05-21 | — | — | US | disclosed |
| US-20150141663-A1 | Fused Ring Indeno Compounds For Preparation Of Photochromic Compounds | TRANSITIONS OPTICAL, INC. (US) | 2015-05-21 | — | — | US | disclosed |
| US-20150141662-A1 | Method Of Preparing Fused Ring Indeno Compounds | TRANSITIONS OPTICAL, INC. (US) | 2015-05-21 | — | — | US | disclosed |
| US-9029565-B1 | Fused ring indeno compounds for preparation of photochromic compounds | TRANSITIONS OPTICAL, INC. (US) | 2015-05-12 | — | — | US | disclosed |
| US-9029565-B1 | Fused ring indeno compounds for preparation of photochromic compounds | TRANSITIONS OPTICAL, INC. (US) | 2015-05-12 | — | — | US | disclosed |
| EP-2098513-B1 | TRICYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOF | TAKEDA PHARMACEUTICAL (JP) | 2015-01-21 | — | — | EP | disclosed |
| US-8853342-B2 | Crosslinkable liquid crystalline polymer | TICONA LLC (US) | 2014-10-07 | — | — | US | disclosed |
| US-20140296514-A1 | ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN | APOLLO ADMINISTRATIVE AGENCY LLC, AS SUCCESSOR AGENT | 2014-10-02 | — | — | US | disclosed |
| US-20140272468-A1 | PHOTOCHROMIC ARTICLES THAT INCLUDE PHOTOCHROMIC-DICHROIC MATERIALS | TRANSITIONS OPTICAL, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140272468-A1 | PHOTOCHROMIC ARTICLES THAT INCLUDE PHOTOCHROMIC-DICHROIC MATERIALS | TRANSITIONS OPTICAL, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| US-8822628-B2 | Crosslinkable liquid crystalline polymer | TICONA LLC (US) | 2014-09-02 | — | — | US | disclosed |
| CN-104003995-A | Pyrone-[3, 4-b] indole derivative and synthetic method thereof | UNIV SHANGHAI JIAOTONG | 2014-08-27 | — | — | CN | disclosed |
| US-8816127-B2 | Carboxylation of terminal alkynes | AGENCY FOR SCIENCE TECHNOLOGY AND RESEARCH (SG) | 2014-08-26 | — | — | US | disclosed |
| US-8791101-B2 | Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin | ALBANY MOLECULAR RESEARCH, INC. (US) | 2014-07-29 | — | — | US | disclosed |
| WO-2014094961-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2014-06-26 | — | — | WO | disclosed |
| CN-102209711-B | Compounds for the treatment of hepatitis C | BRISTOL MYERS SQUIBB CO | 2014-06-18 | — | — | CN | disclosed |
| CN-103864783-A | Compounds for the Treatment of Hepatitis C | BRISTOL MYERS SQUIBB CO | 2014-06-18 | — | — | CN | disclosed |
| US-20140088285-A1 | Crosslinkable Liquid Crystalline Polymer | TICONA LLC (US) | 2014-03-27 | — | — | US | disclosed |
| US-20140088284-A1 | Crosslinkable Liquid Crystalline Polymer | TICONA LLC (US) | 2014-03-27 | — | — | US | disclosed |
| US-20140088247-A1 | Crosslinkable Aromatic Polyester | TICONA LLC (US) | 2014-03-27 | — | — | US | disclosed |
| WO-2014047015-A1 | CROSSLINKABLE AROMATIC POLYESTER | TICONA LLC (US) | 2014-03-27 | — | — | WO | disclosed |
| EP-2684881-A1 | COMPOUND HAVING FLUORESCENT CHROMOPHORE, ION CONCENTRATION SENSOR INCLUDING COMPOUND, REAGENT INCLUDING COMPOUND, REAGENT KIT PROVIDED WITH REAGENT, PRECURSOR OF COMPOUND, AND METHOD FOR SYNTHESIZING COMPOUND | National University Corporation Hokkaido University (JP) | 2014-01-15 | — | — | EP | disclosed |
| US-20140005410-A1 | Compound Having Fluorescent Chromophore, Ion Concentration Sensor Including Compound, Reagent Including Compound, Reagent Kit Provided with Reagent, Precursor of Compound, and Method for Synthesizing Compound | NATIONAL UNIVERSITY CORPORATION, HOKKAIDO UNIVERSITY (JP) | 2014-01-02 | — | — | US | disclosed |
| US-20130331378-A1 | PYRAZOLOPYRIDINE DERIVATIVE OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2013-12-12 | — | — | US | disclosed |
| CN-103443101-A | Compound having fluorescent chromophore, ion concentration sensor comprising the compound, reagent comprising the compound, reagent kit provided with the reagent, precursor of the compound, and method for synthesizing the compound | UNIV HOKKAIDO NAT UNIV CORP | 2013-12-11 | — | — | CN | disclosed |
| EP-2669285-A1 | PYRAZOLOPYRIDINE DERIVATIVE OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF | Kyorin Pharmaceutical Co., Ltd. (JP) | 2013-12-04 | — | — | EP | disclosed |
| US-8582192-B2 | Polarizing photochromic articles | TRANSITIONS OPTICAL, INC. (US) | 2013-11-12 | — | — | US | disclosed |
| US-8582192-B2 | Polarizing photochromic articles | TRANSITIONS OPTICAL, INC. (US) | 2013-11-12 | — | — | US | disclosed |
| US-8536338-B2 | Compounds for the treatment of hepatitis C | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-09-17 | — | — | US | disclosed |
| US-8518546-B2 | Photochromic compounds and compositions | TRANSITIONS OPTICAL, INC. (US) | 2013-08-27 | — | — | US | disclosed |
| US-8518546-B2 | Photochromic compounds and compositions | TRANSITIONS OPTICAL, INC. (US) | 2013-08-27 | — | — | US | disclosed |
| CN-103159761-A | Simple preparation method of 3-aryl indolizine derivative | HUAIYIN TEACHER COLLEGE | 2013-06-19 | — | — | CN | disclosed |
| CN-102958888-A | Carboxylation of terminal alkynes | AGENCY SCIENCE TECH & RES | 2013-03-06 | — | — | CN | disclosed |
| CN-102906089-A | Compounds for the treatment of hepatitis C | BRISTOL MYERS SQUIBB CO | 2013-01-30 | — | — | CN | disclosed |
| EP-2545050-A1 | COMPOUNDS FOR THE TREATMENT OF HEPATITIS C | Bristol-Myers Squibb Company (US) | 2013-01-16 | — | — | EP | disclosed |
| US-20120323038-A1 | CARBOXYLATION OF TERMINAL ALKYNES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-12-20 | — | — | US | disclosed |
| US-8324199-B2 | Pyridazine derivatives as factor xia inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-12-04 | — | — | US | disclosed |
| EP-2513029-A1 | CARBOXYLATION OF TERMINAL ALKYNES | Agency For Science, Technology And Research (SG) | 2012-10-24 | — | — | EP | disclosed |
| US-8293909-B2 | Compounds for the treatment of hepatitis C | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-10-23 | — | — | US | disclosed |
| US-8273761-B2 | Tricyclic compound and medical use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-09-25 | — | — | US | disclosed |
| US-20120232099-A1 | Compounds for the Treatment of Hepatitis C | BRISTOL-MYERS SQUIBB COMPANY | 2012-09-13 | — | — | US | disclosed |
| US-8247429-B2 | Tricyclic compound and pharmaceutical use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-08-21 | — | — | US | disclosed |
| WO-2012082383-A1 | PHOTOCHROMIC COMPOUNDS AND COMPOSITIONS | TRANSITIONS OPTICAL, INC. (US) | 2012-06-21 | — | — | WO | disclosed |
| US-8198449-B2 | Compounds for the treatment of hepatitis C | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-06-12 | — | — | US | disclosed |
| US-8153839-B2 | Method for synthesis of keto acids or amino acids by hydration of acetylene compound | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2012-04-10 | — | — | US | disclosed |
| EP-2100895-B1 | TRICYCLIC COMPOUND AND MEDICAL USE THEREOF | TAKEDA PHARMACEUTICAL (JP) | 2012-03-07 | — | — | EP | disclosed |
| US-20120010220-A1 | SPIROINDOLINEPIPERIDINE DERIVATIVES | SYNGENTA CROP PROTECTION LLC (US) | 2012-01-12 | — | — | US | disclosed |
| US-20110279883-A1 | POLARIZING PHOTOCHROMIC ARTICLES | TRANSITIONS OPTICAL, INC. (US) | 2011-11-17 | — | — | US | disclosed |
| US-20110279883-A1 | POLARIZING PHOTOCHROMIC ARTICLES | TRANSITIONS OPTICAL, INC. (US) | 2011-11-17 | — | — | US | disclosed |
| CN-102209711-A | Compounds for the treatment of hepatitis c | BRISTOL MYERS SQUIBB CO | 2011-10-05 | — | — | CN | disclosed |
| WO-2011112186-A1 | COMPOUNDS FOR THE TREATMENT OF HEPATITIS C | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-09-15 | — | — | WO | disclosed |
| US-7989450-B2 | Functionalized diarylisoxazoles inhibitors of ciclooxygenase | UNIVERSITA' DEGLI STUDI DI BARI (IT) | 2011-08-02 | — | — | US | disclosed |
| US-7989450-B2 | Functionalized diarylisoxazoles inhibitors of ciclooxygenase | UNIVERSITA' DEGLI STUDI DI BARI (IT) | 2011-08-02 | — | — | US | disclosed |
| WO-2011075087-A1 | CARBOXYLATION OF TERMINAL ALKYNES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-06-23 | — | — | WO | disclosed |
| US-20110143141-A1 | Photochromic compounds and compositions | TRANSITIONS OPTICAL, INC. (US) | 2011-06-16 | — | — | US | disclosed |
| US-20110143141-A1 | Photochromic compounds and compositions | TRANSITIONS OPTICAL, INC. (US) | 2011-06-16 | — | — | US | disclosed |
| EP-2331502-A2 | COMPOUNDS FOR THE TREATMENT OF HEPATITIS C | Bristol-Myers Squibb Company (US) | 2011-06-15 | — | — | EP | disclosed |
| US-7956050-B2 | Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin | ALBANY MOLECULAR RESEARCH, INC. (US) | 2011-06-07 | — | — | US | disclosed |
| WO-2011034828-A1 | SUBSTITUTED PARA-BIPHENYLOXYMETHYL DIHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF | SANOFI-AVENTIS (FR) | 2011-03-24 | — | — | WO | disclosed |
| US-20110046114-A1 | ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN | ALBANY MOLECULAR RESEARCH, INC. (US) | 2011-02-24 | — | — | US | disclosed |
| US-20110021492-A1 | PYRIDAZINE DERIVATIVES AS FACTOR XIA INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2011-01-27 | — | — | US | disclosed |
| US-20100184800-A1 | Compounds for the Treatment of Hepatitis C | BRISTOL-MYERS SQUIBB COMPANY | 2010-07-22 | — | — | US | disclosed |
| WO-2010030538-A2 | COMPOUNDS FOR THE TREATMENT OF HEPATITIS C | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-03-18 | — | — | WO | disclosed |
| US-20100063068-A1 | Compounds for the Treatment of Hepatitis C | BRISTOL-MYERS SQUIBB COMPANY | 2010-03-11 | — | — | US | disclosed |
| US-7674823-B2 | DNA-PK inhibitors | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2010-03-09 | — | — | US | disclosed |
| US-7659353-B2 | Hyperbranched polymers | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2010-02-09 | — | — | US | disclosed |
| US-20100029707-A1 | TRICYCLIC COMPOUND AND MEDICAL USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-02-04 | — | — | US | disclosed |
| US-20100010038-A1 | TRICYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOF | 00 | 2010-01-14 | — | — | US | disclosed |
| CN-101622233-A | Tricyclic compound and pharmaceutical use thereof | TAKEDA PHARMACEUTICAL | 2010-01-06 | — | — | CN | disclosed |
| CN-101605795-A | Tricyclic compounds and pharmaceutical uses thereof | TAKEDA PHARMACEUTICAL (JP) | 2009-12-16 | — | — | CN | disclosed |
| EP-2100895-A1 | TRICYCLIC COMPOUND AND MEDICAL USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2009-09-16 | — | — | EP | disclosed |
| EP-2098513-A1 | TRICYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2009-09-09 | — | — | EP | disclosed |
| US-20090216044-A1 | METHOD FOR SYNTHESIS OF KETO ACIDS OR AMINO ACIDS BY HYDRATION OF ACETYLENE COMPOUND | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2009-08-27 | — | — | US | disclosed |
| US-20090181970-A1 | Functionalized diarylisoxazoles inhibitors of ciclooxygenase | UNIVERSITA' DEGLI STUDI DI BARI (IT) | 2009-07-16 | — | — | US | disclosed |
| US-20090181970-A1 | Functionalized diarylisoxazoles inhibitors of ciclooxygenase | UNIVERSITA' DEGLI STUDI DI BARI (IT) | 2009-07-16 | — | — | US | disclosed |
| US-20090118260-A1 | ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN | AMR TECHNOLOGY, INC. (US) | 2009-05-07 | — | — | US | disclosed |
| US-20080207595-A9 | Psychological disorders; analgesics; hyperactivity; eating disorders | AMR TECHNOLOGY, INC. (US) | 2008-08-28 | — | — | US | disclosed |
| EP-1932824-A1 | METHOD FOR SYNTHESIS OF KETO ACID OR AMINO ACID BY HYDRATION OF ACETHYLENE COMPOUND | Japan Science and Technology Agency (JP) | 2008-06-18 | — | — | EP | disclosed |
| EP-1904069-A2 | ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN | AMR Technology, Inc. (US) | 2008-04-02 | — | — | EP | disclosed |
| CN-100357274-C | Diaryl-enynes | NPS ALLELIX CORP (CA) | 2007-12-26 | — | — | CN | disclosed |
| US-20070238729-A1 | DNA-PK INHIBITORS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2007-10-11 | — | — | US | disclosed |
| US-7226918-B2 | DNA-PK inhibitors | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2007-06-05 | — | — | US | disclosed |
| US-20070021408-A1 | Psychological disorders; analgesics; eating disorders; drug abuse | AMR TECHNOLOGY, INC. (US) | 2007-01-25 | — | — | US | disclosed |
| WO-2007011820-A2 | ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN | AMR TECHNOLOGY, INC. (US) | 2007-01-25 | — | — | WO | disclosed |
| EP-1618088-A1 | STABILIZED ORGANIC PEROXIDE COMPOSITION AND PROCESS FOR MAKING THE SAME | CHEMTURA CORPORATION (US) | 2006-01-25 | — | — | EP | disclosed |
| EP-1224189-B1 | CONDENSED DIHYDROQUINOLINONE DERIVATIVES FOR INHIBITING MRP1 | LILLY CO ELI (US) | 2006-01-25 | — | — | EP | disclosed |
| US-20050209459-A1 | Processes for the preparation of 1,5-diryl-3-substituted-pyrazoles | REDDY M V R | 2005-09-22 | — | — | US | disclosed |
| US-6936632-B2 | Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof | MERCKLE GMBH (DE) | 2005-08-30 | — | — | US | disclosed |
| CN-1653042-A | Aminoalcohol derivatives as beta-3 adrenergic receptor agonists | FUJISAWA PHARMACEUTICAL CO (JP) | 2005-08-10 | — | — | CN | disclosed |
| US-20050164899-A1 | Hyperbranched polymers | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2005-07-28 | — | — | US | disclosed |
| US-6921777-B2 | Heteroethynylenic compounds and pharmaceutical and cosmetic compositions containing them | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 2005-07-26 | — | — | US | disclosed |
| US-6906196-B2 | Processes for the preparation of 1,5-diaryl-3-substituted-pyrazoles | ONCONOVA THERAPEUTICS, INC. (US) | 2005-06-14 | — | — | US | disclosed |
| US-6893584-B2 | Stabilized organic peroxide composition and process for making the same | CROMPTON CORPORATION (US) | 2005-05-17 | — | — | US | disclosed |
| US-20050090669-A1 | Aminoalcohol derivatives as beta-3 adrenergic receptor agonists | ASTELLAS PHARMA INC. (JP) | 2005-04-28 | — | — | US | disclosed |
| EP-1436285-A4 | PROCESSES FOR THE PREPARATION OF 1,5-DIARYL-3-SUBSTITUTED-PYRAZOLES | ONCONOVA THERAPEUTICS INC (US) | 2004-12-15 | — | — | EP | disclosed |
| EP-1483236-A1 | AMINOALCOHOL DERIVATIVES AS BETA-3 ADRENERGIC RECEPTOR AGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-12-08 | — | — | EP | disclosed |
| WO-2004096762-A1 | STABILIZED ORGANIC PEROXIDE COMPOSITION AND PROCESS FOR MAKING THE SAME | CHEMTURA CORPORATION (US) | 2004-11-11 | — | — | WO | disclosed |
| US-20040211938-A1 | Stabilized organic peroxide composition and process for making the same | CROMPTON CORPORATION | 2004-10-28 | — | — | US | disclosed |
| EP-1436285-A2 | PROCESSES FOR THE PREPARATION OF 1,5-DIARYL-3-SUBSTITUTED-PYRAZOLES | Onconova Therapeutics, Inc. (US) | 2004-07-14 | — | — | EP | disclosed |
| US-20040122002-A1 | Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof | MERCKLE GMBH (DE) | 2004-06-24 | — | — | US | disclosed |
| EP-1226108-A4 | DIARYL-ENYNES | NPS ALLELIX CORP (CA) | 2004-06-16 | — | — | EP | disclosed |
| US-20040077675-A1 | Compounds and methods for inhibiting MRP1 | BONJOUKLIAN ROSANNE (US) | 2004-04-22 | — | — | US | disclosed |
| US-6706927-B2 | INTERMEDIATES IN PREPARATION OF 1,5-DIARYLPYRAZOLE ANTIINFLAMMATORY AGENTS | ONCONOVA THERAPEUTICS, INC. | 2004-03-16 | — | — | US | disclosed |
| US-6670373-B1 | Inhibiting resistant neoplasms where the resistance is conferred by multidrug resistance protein; N-3,4,5-trimethoxyphenyl-3-(3-azidomethyl-isoxazolo(4,5-c) -1,2-dihydro-6-chloro-quinolin-2-on-1-yl)phenylacetamide | ELI LILLY AND COMPANY | 2003-12-30 | — | — | US | disclosed |
| EP-1246825-B1 | FUSED PYRROLE COMPOUNDS, PHARMACEUTICAL AGENTS CONTAINING THE SAME, AND THE USE THEREOF | MERCKLE GMBH (DE) | 2003-12-17 | — | — | EP | disclosed |
| US-20030225232-A1 | Hyperbranched polymers | HONG KONG UNIVERSITY OF SCIENCE & TECHNOLOGY, THE (HK) | 2003-12-04 | — | — | US | disclosed |
| US-20030199707-A1 | ALKYNE KETONES | ONCONOVA THERAPEUTICS, INC. | 2003-10-23 | — | — | US | disclosed |
| WO-2003076397-A1 | AMINOALCOHOL DERIVATIVES AS BETA-3 ADRENERGIC RECEPTOR AGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-09-18 | — | — | WO | disclosed |
| US-6579987-B2 | Reducing an ester containing ene-yne conjugated, silane and aryl or heteroaryl functionality to an alcohol; bromination, amination, desilanation, coupling and deprotecting | NPS ALLELIX CORPORATION (CA) | 2003-06-17 | — | — | US | disclosed |
| US-6579988-B2 | Condensation cyclization of an alkyne and a para-sulfone or sulfonamide phenyl hydrazine | ONCONOVA THERAPEUTICS, INC. | 2003-06-17 | — | — | US | disclosed |
| US-20030109709-A1 | Processes for the preparation of 1,5-diaryl-3-substituted-pyrazoles | ONCONOVA THERAPEUTICS, INC. | 2003-06-12 | — | — | US | disclosed |
| US-20030096853-A1 | PROCESSES FOR THE PREPARATION OF 1,5-DIARYLPYRAZOLES | ONCONOVA THERAPEUTICS, INC. | 2003-05-22 | — | — | US | disclosed |
| US-20030092769-A1 | DIARYL-ENYNES | NPS ALLELIX CORPORATION (CA) | 2003-05-15 | — | — | US | disclosed |
| WO-2003024958-A2 | PROCESSES FOR THE PREPARATION OF 1,5-DIARYL-3-SUBSTITUTED-PYRAZOLES | ONCONOVA THERAPEUTICS, INC. (US) | 2003-03-27 | — | — | WO | disclosed |
| WO-2003024400-A2 | PROCESS FOR THE PREPARATION OF 1,5-DIARYLPYRAZOLES | ONCONOVA THERAPEUTICS, INC. (US) | 2003-03-27 | — | — | WO | disclosed |
| US-6525085-B2 | Treating neurological and neuropsychiatric disorders | NPS ALLELIX CORP. (CA) | 2003-02-25 | — | — | US | disclosed |
| US-20030012803-A1 | Novel heteroethynylenic compounds and pharmaceutical and cosmetic compositions containing them | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2003-01-16 | — | — | US | disclosed |
| CN-1387507-A | diaryl enynes | NPS ALLELIX CORP (CA) | 2002-12-25 | — | — | CN | disclosed |
| US-20020169197-A1 | Diaryl-enynes | NPS ALLELIX CORP. | 2002-11-14 | — | — | US | disclosed |
| US-6444709-B1 | SKIN DISORDERS; ANTIINFLAMMATORY AGENTS; ANTIARTHRITIC AGENTS; CARDIOVASCULAR DISORDERS | GALDERMA RESEARCH & DEVELOPMENT S.N.C. (FR) | 2002-09-03 | — | — | US | disclosed |
| EP-1226108-A1 | DIARYL-ENYNES | NPS Allelix Corp. (CA) | 2002-07-31 | — | — | EP | disclosed |
| US-6426364-B1 | NERVOUS SYSTEM OR PSYCHOLOGICAL DISORDERS | NPS ALLELIX CORP. (CA) | 2002-07-30 | — | — | US | disclosed |
| EP-1224189-A2 | CONDENSED DIHYDROQUINOLINONE DERIVATIVES FOR INHIBITING MRP1 | ELI LILLY AND COMPANY (US) | 2002-07-24 | — | — | EP | disclosed |
| WO-2001032602-A1 | DIARYL-ENYNES | NPS ALLELIX CORP. (CA) | 2001-05-10 | — | — | WO | disclosed |
| WO-2001027116-A2 | CONDENSED DIHYDROQUINOLINONE DERIVATIVES FOR INHIBITING MRP1 | ELI LILLY AND COMPANY (US) | 2001-04-19 | — | — | WO | disclosed |
| US-5750545-A | EXHIBIT EOSINOPHIL-INHIBITORY ACTION AND LYMPHOCYTE ACTIVATION-INHIBITORY ACTION; USEFUL FOR TREATMENT OF IMMUNE-RELATED DISEASES | THE GREEN CROSS CORPORATION (JP) | 1998-05-12 | — | — | US | disclosed |
| US-5663393-A | CYCLIZATION; DECYCLIZATION; HYDROLYSIS; HYDROGENATION | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1997-09-02 | — | — | US | disclosed |
| US-5637739-A | ORGANOMETALLIC CATALYSTS FOR ENANTIOSELECTIVELY EPOXIDIZING PROCHIRAL OLEFINS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1997-06-10 | — | — | US | disclosed |
| EP-0710654-A1 | TRIAZOLE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | THE GREEN CROSS CORPORATION (JP) | 1996-05-08 | — | — | EP | disclosed |
| US-4946861-A | TREATMENT OF LIVER DISORDERS | ZYMA SA (CH) | 1990-08-07 | — | — | US | disclosed |
| US-4818765-A | TREATING LIVER, RESPIRATORY TRACT, VASCULAR DISORDERS | CIBA-GEIGY CORPORATION (US) | 1989-04-04 | — | — | US | disclosed |
| US-4650749-A | BASE PRECURSOR | FUJI PHOTO FILM CO., LTD. (JP) | 1987-03-17 | — | — | US | disclosed |
| US-4647526-A | Heat-developable light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 1987-03-03 | — | — | US | disclosed |
| EP-0099329-A1 | Dithio compounds, pharmaceutical preparations containing them and their use | Zyma SA (CH) | 1984-01-25 | — | — | EP | disclosed |
| JP-S5697250-A | PREPARATION OF ACETYLENECARBOXYLIC ESTER | NIPPON ZEON CO LTD | 1981-08-05 | — | — | JP | disclosed |
| US-4249027-A | Process for the preparation of 5-substituted resorcinols and related intermediates | CIBA-GEIGY CORPORATION (US) | 1981-02-03 | — | — | US | disclosed |
| US-4020098-A | Process for the preparation of 5-substituted resorcinols and related intermediates | CIBA-GEIGY CORPORATION (US) | 1977-04-26 | — | — | US | disclosed |
| US-4020098-A | Process for the preparation of 5-substituted resorcinols and related intermediates | CIBA-GEIGY CORPORATION (US) | 1977-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (48 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110143141-A1 | Photochromic compounds and compositions | CCNA1, CRY1, CCNT1 | NPSR1 4217/4885NPC1 2910/4885RAB9A 1829/4885 |
| US-20050209459-A1 | Processes for the preparation of 1,5-diryl-3-substituted-pyrazoles | CYP2E1, CYP1A1, CYP1B1 | NPSR1 2524/4885NPC1 1330/4885RAB9A 1610/4885 |
| US-20200350502-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBP, OSBPL3, OSBP2 | NPSR1 1630/4885NPC1 591/4885RAB9A 2018/4885 |
| US-12263159-B2 | Fused ring compound having urea structure | NAMPT, NME4, NDUFAB1 | NPSR1 2131/4885NPC1 869/4885RAB9A 854/4885 |
| US-20210361636-A1 | FUSED RING COMPOUND HAVING UREA STRUCTURE | NAMPT, NME4, ABAT | NPSR1 2204/4885NPC1 973/4885RAB9A 871/4885 |
| US-20110021492-A1 | PYRIDAZINE DERIVATIVES AS FACTOR XIA INHIBITORS | F11, F12, TFPI2 | NPSR1 1694/4885NPC1 3955/4885RAB9A 3597/4885 |
| US-12083101-B2 | Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors | YAP1, TEAD3, TEAD2 | NPSR1 4657/4885NPC1 1410/4885RAB9A 418/4885 |
| US-20150333280-A1 | Metal Complexes | SOD1, AP1M1, AP3M1 | NPSR1 3952/4885NPC1 3516/4885RAB9A 2201/4885 |
| US-12075691-B2 | Organic electroluminescent materials and devices | OSBP, OSBPL3, OSBP2 | NPSR1 1630/4885NPC1 591/4885RAB9A 2018/4885 |
| US-11918568-B2 | Fused ring compound having urea structure | NAMPT, NME4, ABAT | NPSR1 2204/4885NPC1 973/4885RAB9A 871/4885 |
| US-20150141662-A1 | Method Of Preparing Fused Ring Indeno Compounds | INHA, INTS9, CA9 | NPSR1 2674/4885NPC1 3007/4885RAB9A 1277/4885 |
| US-20240397811-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBP, OSBPL3, OSBP2 | NPSR1 1630/4885NPC1 591/4885RAB9A 2018/4885 |
| US-20130331378-A1 | PYRAZOLOPYRIDINE DERIVATIVE OR PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF | PTGER1, OXER1, OXSR1 | NPSR1 175/4885NPC1 3225/4885RAB9A 2298/4885 |
| US-20150141663-A1 | Fused Ring Indeno Compounds For Preparation Of Photochromic Compounds | IPO5, INCENP, NQO1 | NPSR1 3673/4885NPC1 1563/4885RAB9A 832/4885 |
| US-20090181970-A1 | Functionalized diarylisoxazoles inhibitors of ciclooxygenase | PTGIS, ALOX5, ALOX15 | NPSR1 1661/4885NPC1 4823/4885RAB9A 4628/4885 |
| US-20240285597-A1 | FUSED RING COMPOUND HAVING UREA STRUCTURE | NAMPT, NME4, NDUFAB1 | NPSR1 2131/4885NPC1 869/4885RAB9A 854/4885 |
| US-20240382457-A1 | BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS | YAP1, TEAD3, TEAD2 | NPSR1 4657/4885NPC1 1410/4885RAB9A 418/4885 |
| US-20100010038-A1 | TRICYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOF | MTNR1A, MTNR1B, XDH | NPSR1 224/4885NPC1 1929/4885RAB9A 4000/4885 |
| US-20030012803-A1 | Novel heteroethynylenic compounds and pharmaceutical and cosmetic compositions containing them | TYR, CYP1B1, MITF | NPSR1 1200/4885NPC1 681/4885RAB9A 704/4885 |
| US-20160060205-A1 | Method Of Preparing Fused Ring Indeno Compounds | INHA, INTS9, CA9 | NPSR1 2674/4885NPC1 3007/4885RAB9A 1277/4885 |
| US-20100063068-A1 | Compounds for the Treatment of Hepatitis C | HAVCR2, HCCS, SLC10A1 | NPSR1 3467/4885NPC1 59/4885RAB9A 2261/4885 |
| US-20080207595-A9 | Psychological disorders; analgesics; hyperactivity; eating disorders | OPRL1, HTR1B, HTR3C | NPSR1 50/4885NPC1 1700/4885RAB9A 483/4885 |
| US-20120010220-A1 | SPIROINDOLINEPIPERIDINE DERIVATIVES | RECQL, OPRD1, SKP1 | NPSR1 408/4885NPC1 1437/4885RAB9A 54/4885 |
| US-20100184800-A1 | Compounds for the Treatment of Hepatitis C | HAVCR2, HCCS, SLC10A1 | NPSR1 3467/4885NPC1 59/4885RAB9A 2261/4885 |
| US-20100029707-A1 | TRICYCLIC COMPOUND AND MEDICAL USE THEREOF | MTNR1A, MTNR1B, AHR | NPSR1 146/4885NPC1 2149/4885RAB9A 4380/4885 |
| US-20070021408-A1 | Psychological disorders; analgesics; eating disorders; drug abuse | OPRD1, OPRK1, OPRL1 | NPSR1 29/4885NPC1 1659/4885RAB9A 364/4885 |
| US-20030096853-A1 | PROCESSES FOR THE PREPARATION OF 1,5-DIARYLPYRAZOLES | CBR1, CYP1A1, CYP1B1 | NPSR1 1154/4885NPC1 2121/4885RAB9A 2545/4885 |
| US-20140296514-A1 | ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN | ADRA2B, ADRA2C, HTR2B | NPSR1 75/4885NPC1 872/4885RAB9A 224/4885 |
| US-20030199707-A1 | ALKYNE KETONES | CBR1, CBR3, CYC1 | NPSR1 1594/4885NPC1 911/4885RAB9A 3012/4885 |
| US-20070238729-A1 | DNA-PK INHIBITORS | ATM, CHEK2, CHEK1 | NPSR1 3392/4885NPC1 2558/4885RAB9A 4426/4885 |
| US-20150141661-A1 | Photochromic Indeno-Fused Ring Pyran Compounds | INF2, INCENP, RB1 | NPSR1 2965/4885NPC1 4606/4885RAB9A 1338/4885 |
| US-20040077675-A1 | Compounds and methods for inhibiting MRP1 | ABCC1, ABCB1, ABCB11 | NPSR1 3966/4885NPC1 17/4885RAB9A 1749/4885 |
| US-20120323038-A1 | CARBOXYLATION OF TERMINAL ALKYNES | AOC3, CBR1, PCCA | NPSR1 2940/4885NPC1 1156/4885RAB9A 4420/4885 |
| US-20120232099-A1 | Compounds for the Treatment of Hepatitis C | HAVCR2, HCCS, SLC10A1 | NPSR1 3467/4885NPC1 59/4885RAB9A 2261/4885 |
| US-20090216044-A1 | METHOD FOR SYNTHESIS OF KETO ACIDS OR AMINO ACIDS BY HYDRATION OF ACETYLENE COMPOUND | AADAT, BCAT2, BCAT1 | NPSR1 2026/4885NPC1 3380/4885RAB9A 2882/4885 |
| US-20180051037-A1 | Photochromic Thienochromene Compounds | CRY1, CRY2, TERT | NPSR1 3788/4885NPC1 3319/4885RAB9A 1990/4885 |
| US-20240034723-A1 | PIPERIDINYL SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE | IKZF2, IKZF1, NUTF2 | NPSR1 2049/4885NPC1 2342/4885RAB9A 4461/4885 |
| US-20110046114-A1 | ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN | ADRA2B, ADRA2C, HTR2B | NPSR1 75/4885NPC1 872/4885RAB9A 224/4885 |
| US-20260028554-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING AROMATIC DERIVATIVES | TAS2R42, TAS2R4, TAS2R41 | NPSR1 2821/4885NPC1 168/4885RAB9A 4019/4885 |
| US-20090118260-A1 | ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN | ADRA2B, ADRA2C, HTR2B | NPSR1 75/4885NPC1 872/4885RAB9A 224/4885 |
| US-20260078120-A1 | SUBSTITUTED PYRIDOPYRIMIDINONES | CBR1, CBR3, CNR1 | NPSR1 336/4885NPC1 397/4885RAB9A 1597/4885 |
| US-20210299100-A1 | BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS | YAP1, TEAD3, TEAD2 | NPSR1 4666/4885NPC1 1326/4885RAB9A 400/4885 |
| US-20160007608-A1 | SPIROINDOLINEPIPERIDINE DERIVATIVES | RECQL, OPRD1, SKP1 | NPSR1 408/4885NPC1 1437/4885RAB9A 54/4885 |
| US-20040122002-A1 | Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof | PTGS1, PTGS2, PTGER1 | NPSR1 500/4885NPC1 4438/4885RAB9A 3686/4885 |
| US-20020169197-A1 | Diaryl-enynes | CBR3, CNR1, NR3C2 | NPSR1 82/4885NPC1 1702/4885RAB9A 1622/4885 |
| US-20030092769-A1 | DIARYL-ENYNES | CBR3, CNR1, CBR1 | NPSR1 81/4885NPC1 1696/4885RAB9A 1638/4885 |
| US-20050090669-A1 | Aminoalcohol derivatives as beta-3 adrenergic receptor agonists | ADRB2, ADRB1, ADRB3 | NPSR1 188/4885NPC1 4262/4885RAB9A 2056/4885 |
| US-20030109709-A1 | Processes for the preparation of 1,5-diaryl-3-substituted-pyrazoles | CYP1B1, CYP1A1, CYP2E1 | NPSR1 3188/4885NPC1 1230/4885RAB9A 2766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.